We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Kit Allows Rapid Diagnosis of Norovirus

By LabMedica International staff writers
Posted on 11 Dec 2008
An enzyme immunoassay rapidly detects Norovirus, the virus responsible for "winter vomiting disease.” The assay is sensitive, and specific results are available in less than 2 hours, allowing outbreaks to be identified quickly, and enabling measures to contain the outbreak to be initiated as soon as possible.

Called IDEIA (ID enzyme immunoassay) Norovirus, the assay is easy to perform, and detects Norovirus directly in stool samples. More...
It is suitable for manual or automated testing. The rapid and reliable results are of great value to those involved in the investigation and prevention of Norovirus outbreaks, including microbiology laboratories, infection control teams, surveillance teams, epidemiologists, and cruise ship operators.

Norovirus is extremely infectious and spreads rapidly throughout an institution. It is particularly common in semi-closed environments, such as hospitals, nursing homes, schools, and cruise ships, where there is a high concentration of people who are susceptible to infection, namely children, the elderly, and those with underlying disease.

IDEIA Norovirus is one of Oxoid's (Basingstoke, UK) range of IDEIA kits for the detection of the four leading causes of viral gastroenteritis: Norovirus, Rotavirus, astrovirus, and adenovirus. Each kit follows a similar protocol and each can be performed individually or in a panel, using a single sample dilution.

There were several outbreaks of Norovirus this winter (2008-2009), in the United Kingdom affecting hospitals in Norfolk and Somerset, where wards were closed to visitors and new admissions in an attempt to halt the spread of infection. Norovirus was also found on a cruise ship on the Rhine River (Europe), resulting in the hospitalization of elderly holidaymakers.

Related Links:

Oxoid



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-Time PCR System
Gentier 96T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.